Andtbacka Discusses Long-Term Data and Next Steps With T-VEC in Melanoma

Talimogene laherparapvec (T-VEC; Imlygic) continues to demonstrate durable response rates in patients with unresectable stage IIIb, IIIc, and IVM1a melanoma, according to long-term follow-up results from the pivotal phase III OPTiM study.

New international research project identifies subtypes of ocular melanoma

A new international research project, involving the University of Liverpool’s leading eye cancer research group, has identified specific subtypes of ocular melanoma that will help develop improved management strategies and therapies in the future.

Endometriosis Linked to Higher Risk of Melanoma, but Not Other Skin Cancers, Study Suggests

Women with a history of endometriosis may have an increased risk of developing melanoma, but no association was seen in other skin cancers, according to the results of a large prospective analysis.

Long-Term T-VEC Results in Melanoma Provide Reassurance for Clinicians and Patients, Expert Says

According to long-term follow-up results from the pivotal phase III OPTiM study, talimogene laherparapvec (T-VEC; Imlygic) continues to demonstrate durable response rates in patients with unresectable stage IIIb, IIIc, and IVM1a melanoma.

Cancer in the News

Feature Articles

Artificial intelligence helps with earlier detection of skin cancer

New technology being developed by researchers at the University of Waterloo and the Sunnybrook Research Institute is using artificial intelligence (AI) to help detect melanoma skin cancer earlier.

Read the full story

Posted in Melanoma In The News, Information

Dr. Grob on the Tolerability and Efficacy of Ipilimumab in Melanoma

Jean Jacques Grob, MD, PhD, professor of dermatology at the Hospital de la Timone, discusses the tolerability and efficacy of ipilimumab (Yervoy) for melanoma.

Read the full story

Posted in Melanoma In The News, OncLive Videos

Skin cancer rates at record high in Ireland

The rate of skin cancer is at a record high in Ireland, it has emerged. Latest figures show that in 2014 as many as 1,041 people were diagnosed with melanoma in Ireland – the first time the number of incidences here surpassed the 1,000-mark since records began.

Read the full story

Posted in Melanoma In The News, Information, Patient Information

Knowledge of Immunotherapies in Melanoma Continues to Grow

The 2011 U.S. Food and Drug Administration (FDA) approval of immunotherapy ipilimumab was the first in a series of approvals to treated patients with advanced melanoma in recent years.

Read the full story

Posted in Melanoma In The News, Information

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories